
Novo Nordisk’s Weight Loss Bet Tests Investor Patience as Science Plays the Long Game
GLP-1 drugs continue to unlock new medical promise, but mounting competition, falling shares, and looming patents are straining market confidence
249 articles

GLP-1 drugs continue to unlock new medical promise, but mounting competition, falling shares, and looming patents are straining market confidence

Regional markets diverge in the final trading week of the year while silver briefly hits record highs and U.S. equities consolidate near peaks

Muted equity moves contrast with a powerful rally in precious metals amid inflation signals and global policy uncertainty

As analysts hesitate over valuation, everyday investors pour billions into Palantir, betting its AI driven future will mirror past market legends

Why Warren Buffett has repeatedly called buying Berkshire Hathaway his most expensive mistake despite turning it into a trillion dollar empire

A veteran asset manager explains how algorithmic funds deliver results only when humans design, train, and discipline the machines behind every decision
.png)
Regional gains follow Wall Street’s record-setting rally and renewed optimism after the latest Federal Reserve rate cut.

Weak top-line results and soaring capital demands shake investor confidence as Oracle’s aggressive AI infrastructure strategy faces heightened scrutiny.

As hyperscalers pour billions into data centers, chips and power grids, BlackRock bets that hardware, energy and material-supply firms stand to gain most from the AI spending spree.